Home » Stocks » SMLR

Semler Scientific Inc. (SMLR)

Stock Price: $120.00 USD 3.00 (2.56%)
Updated Jul 23, 2021 2:46 PM EDT - Market closed
Market Cap 807.03M
Revenue (ttm) 42.36M
Net Income (ttm) 16.21M
Shares Out 6.71M
EPS (ttm) 2.01
PE Ratio 59.67
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $120.00
Previous Close $117.00
Change ($) 3.00
Change (%) 2.56%
Day's Open 118.00
Day's Range 114.50 - 122.00
Day's Volume 3,651
52-Week Range 48.15 - 129.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...

5 days ago - PRNewsWire

Semler Scientific Inc. (SMLR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the n...

2 weeks ago - Zacks Investment Research

Semler Scientific Inc. (SMLR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago - Zacks Investment Research

SANTA CLARA, Calif., June 10, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...

1 month ago - PRNewsWire

Here are the stocks our experts are keeping their eye on as we head into the summer.

Other stocks mentioned: GHVI, GRBK, RHP, TCEHY
1 month ago - The Motley Fool

Semler Scientific Inc. (SMLR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

1 month ago - Zacks Investment Research

Semler Scientific Inc. (SMLR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

2 months ago - Zacks Investment Research

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 22.45% and 10.32%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

SANTA CLARA, Calif., May 3, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare pr...

2 months ago - PRNewsWire

Semler Scientific Inc. (SMLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

SANTA CLARA, Calif., April 26, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare...

3 months ago - PRNewsWire

SANTA CLARA, Calif., April 7, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...

3 months ago - PRNewsWire

HOLX vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: HOLX
3 months ago - Zacks Investment Research

MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.

Other stocks mentioned: BASI, DGX, HOLX, INMD, LH, RMD
4 months ago - Zacks Investment Research

Semler Scientific Inc. (SMLR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

4 months ago - Zacks Investment Research

HOLX vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: HOLX
4 months ago - Zacks Investment Research

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 46.67% and 5.35%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

SANTA CLARA, Calif., Feb. 25, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...

5 months ago - PRNewsWire

A company most investors have never heard of is beginning to make a name for itself.

5 months ago - The Motley Fool

HOLX vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: HOLX
5 months ago - Zacks Investment Research

SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare p...

6 months ago - PRNewsWire

The pandemic blip seems all but a distant memory for the company even if not all of the risk has cleared. The company just keeps growing and producing awe-inspiring margins, it doesn't happen often one ...

6 months ago - Seeking Alpha

Top Ranked Momentum Stocks to Buy for November 17th

Other stocks mentioned: CTHR, FLGT, RM
8 months ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for November 12th

Other stocks mentioned: GM, HOG, PRSC
8 months ago - Zacks Investment Research

SANTA CLARA, Calif., Nov. 12, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare ...

8 months ago - PRNewsWire

Semler Scientific, Inc. (SMLR) CEO Doug Murphy-Chutorian on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 258.82% and 24.44%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Semler Scientific Inc. (SMLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

Discover how these three companies could change the face of healthcare.

Other stocks mentioned: DMTK, TRUP
8 months ago - The Motley Fool

While the company has experienced headwinds from the pandemic, growth is already returning.

9 months ago - Seeking Alpha

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: FMS
10 months ago - Zacks Investment Research

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: FMS
10 months ago - Zacks Investment Research

No matter what the month, stay the course.

Other stocks mentioned: AMZN, CHWY, PTON, SHOP
10 months ago - The Motley Fool

SAN JOSE, Calif., Aug. 17, 2020 /PRNewswire/ -- Semler Scientific, Inc.

11 months ago - PRNewsWire

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: FMS
11 months ago - Zacks Investment Research

Semler Scientific's (SMLR) CEO Doug Murphy-Chutorian on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 116.67% and -15.48%, respectively, for the quarter ended June 2020.

11 months ago - Zacks Investment Research

All three offer innovative technology that meets major healthcare needs.

Other stocks mentioned: GH, LVGO
11 months ago - The Motley Fool

3 Potentially Undervalued Small-Cap Ideas

Other stocks mentioned: XPEL
11 months ago - Seeking Alpha

There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.

Other stocks mentioned: IDXX, ZYXI
1 year ago - The Motley Fool

Semler Scientific (SMLR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

1 year ago - Zacks Investment Research

I'm putting real money behind these hidden healthcare winners.

Other stocks mentioned: NVCR
1 year ago - The Motley Fool

Semler Scientific is a high growth company with annual sales increasing at a CAGR of 37% since 2015.

1 year ago - Seeking Alpha

The company has simplified the testing of PAD, which is a marker for increased risk of stroke and cardiovascular disease.

1 year ago - Seeking Alpha

Semler Scientific: High-Quality Medical Stock With Cash Flow Growth And Zero Debt

1 year ago - Seeking Alpha

Semler Scientific, Inc. (SMLR) CEO Doug Murphy-Chutorian on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

It's time to get greedy with these beaten-down businesses.

Other stocks mentioned: HQY, PINS
1 year ago - The Motley Fool

Semler Scientific, Inc. (SMLR) CEO Doug Murphy-Chutorian on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

These three companies are all growing like gangbusters and have already reached profitability.

Other stocks mentioned: BYND, FLGT
1 year ago - The Motley Fool

We take a look at three small and promising healthcare companies across diagnostics, surgical products, and genetic testing.

Other stocks mentioned: FLGT, LMAT
1 year ago - The Motley Fool

About SMLR

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance... [Read more...]

Industry
Medical Devices
IPO Date
Feb 21, 2014
CEO
Douglas Murphy-Chutorian
Employees
86
Stock Exchange
OTCMKTS
Ticker Symbol
SMLR
Full Company Profile

Financial Performance

In 2020, SMLR's revenue was $38.60 million, an increase of 17.81% compared to the previous year's $32.77 million. Earnings were $14.01 million, a decrease of -7.14%.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for SMLR is 149.33, which is an increase of 24.44% from the latest price.

Price Target
$149.33
(24.44% upside)